Nucleoside reverse transcriptase inhibitors
AZOLES AS NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NNRTIs): MINI REVIEW
6
Frequency of Mutations Conferring Resistance to Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1 Infected Patients in Korea
7
AN INSIGHT TO STRUCTURAL ANALYSIS OF COUMARINS AS NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
18
Immunogenicity of Mutations Induced by Nucleoside Reverse Transcriptase Inhibitors for Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Cells
7
Comparative Study of Various Non-Nucleoside Reverse Transcriptase Inhibitors on Different Reverse Transcriptase Enzyme
7
HIV-1 and HIV-2 Reverse Transcriptases: Different Mechanisms of Resistance to Nucleoside Reverse Transcriptase Inhibitors
10
Inhibitory activity of 9 phenylcyclohepta[d]pyrimidinedione derivatives against different strains of HIV 1 as non nucleoside reverse transcriptase inhibitors
6
Antiretroviral resistance in HIV 1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis
10
PROGRESS AND PROSPECTS IN THERAPEUTICS AGAINST HIV INFECTION
12
Non-Hepatic Adverse Effects of Antiretroviral Therapy for HIV Treatment and Care
6
Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study
10
Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques
5
Once-Daily Highly Active Antiretroviral Therapy for HIV-Infected Children: Safety and Efficacy of an Efavirenz-Containing Regimen
13
Theoretical Studies of The Contraction and Extension Effect in The B-Ring of TIBO Derivatives
8
jsc140003.pdf
16
The urgent need for more potent antiretroviral therapy in low-income countries to achieve UNAIDS 90-90-90 and complete eradication of AIDS by 2030
8
RECENT ADVANCES AND MANAGEMENT APPRAISAL FOR THE CHEMOTHERAPY OF AIDS
23
Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
5
Volume 2 | Issue 4 - 2012
5
The impact of a UK HIV-1 resistance database for the management and improvement of the clinical care of people living with HIV-1
238